Starred Review. Mukherjee's debut book is a sweeping epic of obsession, brilliant researchers, dramatic new treatments, euphoric success and tragic failure, and the relentless battle by scientists and patients alike against an equally relentless, wily, and elusive enemy. From the first chemotherapy developed from textile dyes to the possibilities emerging from our understanding of cancer cells, Mukherjee shapes a massive amount of history into a coherent story with a roller-coaster trajectory: the discovery of a new treatment--surgery, radiation, chemotherapy--followed by the notion that if a little is good, more must be better, ending in disfiguring radical mastectomy and multidrug chemo so toxic the treatment ended up being almost worse than the disease. The first part of the book is driven by the obsession of Sidney Farber and philanthropist Mary Lasker to find a unitary cure for all cancers. (Farber developed the first successful chemotherapy for childhood leukemia.) The last and most exciting part is driven by the race of brilliant, maverick scientists to understand how cells become cancerous. Each new discovery was small, but as Mukherjee, a Columbia professor of medicine, writes, "Incremental advances can add up to transformative changes." Mukherjee's formidable intelligence and compassion produce a stunning account of the effort to disrobe the "emperor of maladies." (Nov.) (c)
Copyright © Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
Siddhartha Mukherjee is a cancer physician and researcher. He is an assistant professor of medicine at Columbia University and a staff cancer physician at the CU/NYU Presbytarian Hospital. A former Rhodes scholar, he graduated from Stanford University, University of Oxford (where he received a PhD studying cancer-causing viruses) and from Harvard Medical School. His laboratory focuses on discovering new cancer drugs using innovative biological methods. Mukherjee trained in cancer medicine at the Dana Farber Cancer Institute of Harvard Medical School and was on the staff at the Massachusetts General Hospital. He has published articles and commentary in such journals as Nature, New England Journal of Medicine, Neuron and the Journal of Clinical Investigation and in publications such as the New York Times and the New Republic. His work was nominated for Best American Science Writing, 2000 (edited by James Gleick). He lives in Boston and New York with his wife, Sarah Sze, an artist, and with his daughter, Leela.
推荐《众病之王----癌症传》,大牛的科普读物。非常严谨,句子也好读,不晦涩。功课做得真足,年份什么的都好清楚。写作线索也非常明析。太喜欢看这种书了。作者是印裔米国人,把米国所有的牛叉学院都上了个遍。这书写了六年。超值。能把人类病史写得好的,还头一回看到。
评分医学就是医学,没什么中外东西。像癌症这种病,发现它对抗它的必定是一个充满活力充满基础发明创造和认识能力的社会。不单是医学的发展,包括化学、生物学甚至物理学等等各种学科的交融才能从多个角度对这种可怕的病症展开作战,从手术到放疗到化疗到基因攻击,挽救了无数人的...
评分 评分癌症源于我们自身的一些负责调节细胞生长的基础基因的突变。而这种突变基因导致的癌细胞有时会展现出永不停止的分裂。在合适的环境下癌细胞可以一直分裂下去,没有衰老的痕迹,这透露出永生的意味。而这种带着永生意味的分裂却会摧毁我们的身体,带来无可避免的死亡。 这真是...
评分“……可以认为癌症在试图仿效一个再生器官;或者更令人不安的是在仿效一个再生的有机体。其对永生不死的追求反映了我们自己的追求,埋藏在我们的胚胎和器官重生中的一种追求。有一天,如果癌症成功了,它将产生一个比其宿主更加完美的生命,具有不死的特性和增殖的动力。...
除了用科普的笔触去写人类对癌症认知的历史,作者还调查了“和癌症做斗争”的政治和社会运作。几乎是想象中科普作者的最佳语气。就像之前读过这本书的一位朋友说的,在我们这个时代大概每个人都会有机会旁观或亲历对抗癌症的战斗。
评分语言很elegant,内容很充实,病人的故事很煽情。有几个章节有点拖拉。从cytotoxic drugs到antibody那段记得比较清楚。当年的genentech还是很牛的,一片校园风。
评分这本书真是非常的赞,与癌症这个出自人自身的疾病的斗争如此波澜壮阔。
评分伴随着我渡过了纽约律所实习时的地铁时光,有时晚上加班困极了,读着读着就睡着,醒来发现坐过了站,而夜太深local的列车又停运了,只得穿过许多街区走过哥大校园回到出租屋。现在都不知道,让我沮丧的,是关于癌症的论调,还是工作。想起曾经读到过的,别急着觉得自己一无所有,你还可以有病呢。
评分这是一本癌症的传记,这个困扰了人类几千年的疾病。作者是个医生,专业知识扎实,文字又好,功课也做得足。虽然书并不短,但是用四百多页深入浅出的把癌症几千年的历史和近来几百年地医治和研究历讲的生动有力也不是易事。
本站所有内容均为互联网搜索引擎提供的公开搜索信息,本站不存储任何数据与内容,任何内容与数据均与本站无关,如有需要请联系相关搜索引擎包括但不限于百度,google,bing,sogou 等
© 2026 book.wenda123.org All Rights Reserved. 图书目录大全 版权所有